Anavex Life Sciences Corp. (AVXL)
Nasdaq: AVXL · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2005
Who runs Anavex Life Sciences Corp.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kellmeyer Terrie
President and CEO. First filing May 2026, latest Nov 6, 2026, 0 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
11 people on the record since 2006
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kellmeyer Terrie | President and CEO | May 2026 | Nov 6, 2026 | none |
| Boenisch Sandra | PFO & Treasurer | Oct 2015 | Sep 28, 2026 | none |
| Missling Christopher U | President and CEO | Jul 2013 | Jan 9, 2026 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Donhauser Peter D.O. | director | Feb 2017 | Nov 6, 2026 | none |
| Paeger Axel | director | May 2026 | Nov 6, 2026 | none |
| Velden Claus Vander | director | Apr 2018 | Nov 6, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.